Order from Chaos: Observing hormesis at the proteome level

Journal of Proteome Research

Volumn 4, Issue 6, 2005, Pages 2133-2136

  Randić, Milan ^a   Estrada, Ernesto ^a  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

Hormesis; Peroxisome; Proteome perturbation; Proteomics maps

Indexed keywords

PEROXISOME PROLIFERATOR; PROTEOME; TOMELUKAST;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CHEMICAL STRUCTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE RESPONSE; HORMESIS; LIVER CELL; MOUSE; NONHUMAN; PEROXISOME; PRIORITY JOURNAL; PROTEOMICS;

ACETOPHENONES; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; LEUKOTRIENE ANTAGONISTS; LIVER; MICE; MODELS, CHEMICAL; MODELS, STATISTICAL; PEROXISOME PROLIFERATORS; PEROXISOMES; PROTEOME; PROTEOMICS; SYSTEMS BIOLOGY; TETRAZOLES;

ANIMALIA;

EID: 29144516346     PISSN: 15353893     EISSN: None     Source Type: Journal    
DOI: 10.1021/pr050229j     Document Type: Article

References (14)

1. Anderson, N. L.; Matheson, A. D.; Steiner, S. Proteomics. Applications in basic and applied biology. Curr. Opin. Biotech. 2000, 11, 408-412.
2. Tyers, M.; Mann, M. From genomics to proteomics. Nature 2003, 422, 193-197.
3. Begley, T. J.; Rosenbach, A.; Ideker, T.; Samson, L. D. Damage recovery pathways in Saccharomyces cerevisiae revealed by genomic phenotyping and interactome mapping. Mol. Cancer Res. 2002, 1, 103-112.
4. Hughes, T. R. et al. Functional discovery via a compendium of expression profiles. Cell 2000, 102, 109-126.
5. Bilello, J. A. The agony and ecstasy of "OMIC" technologies in drug development. Curr. Mol. Med. 2005, 5, 39-52.
6. Calabrese, E. J.; Baldwin, L. A. Defining hormesis. Human Exp. Toxicol. 2003, 21, 91-97.
7. Calabrese, E. J.; Baldwin, L. A. Hormesis: The dose-response revolution. Annu. Rev. Pharmacol. Toxicol. 2003, 43, 175-197.
8. Calabrese, E. J.; Baldwin, L. A. Toxicology rethinks its central belief. Hormesis demands a reappraisal of the way risks are assessed. Nature 2003, 421, 691-692.
9. Anderson, N. L.; Esquer-Blasco, R.; Richardson, F.; Foxworthy, P.; Eacho, P. The effects of peroxisome proliferators on protein abundances in mouse liver. Toxicol. Appl. Pharmacol. 1996, 137, 75-89.
10. Randić, M.; Novič, M.; Vračko, M. On characterization of dose variations of 2-D proteomics maps by matrix invariant. J. Proteome Res. 2002, 1, 217-2268.
11. Stebbing, A. R. D. A theory for growth hormesis. Mutat. Res. 1998, 403, 249-258.
12. Steiner, S.; Anderson, N. L. Expression profiling in toxicology- potentials and limitations. Toxicol. Lett. 2000, 112-113, 467-471.
13. Bandara, L. R.; Kennedy, S. Toxicoproteomics-a new preclinical tool. DDT 2002, 7, 411-418.
14. Waters, M. D.; Fostel, J. M. Toxicogenomics and systems toxicology: Aims and prospects. Nat. Rev. Genet. 2004, 5, 936-948.